½ÃÀ庸°í¼­
»óǰÄÚµå
1593908

MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

MRI Guided Neurosurgical Ablation Market by Product (Accessories, MRI Guided Focused Ultrasound Systems, MRI Guided Laser Ablation Systems), End User (Ambulatory Surgical Centers, Clinics, Hospitals) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀåÀº 2023³â¿¡ 38¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 40¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 4.84%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 54¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

MRI À¯µµÇÏ ½Å°æ¿Ü°úÀû ÀýÁ¦¼úÀÇ ¹üÀ§´Â ³ú Á¶Á÷À» ÀýÁ¦Çϰųª Á¦°ÅÇϱâ À§ÇÑ ÃÖ¼Òħ½ÀÀû ¼ö¼úÀÇ ÁöħÀ¸·Î MRI ±â¼úÀ» »ç¿ëÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ±â¼úÀº º´º¯ÀÇ Á¤È®ÇÑ Ç¥ÀûÈ­¸¦ °¡´ÉÇÏ°Ô Çϰí ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ÀáÀçÀû ¼Õ»óÀ» ÁÙÀÓÀ¸·Î½á ȯÀÚÀÇ ¿¹ÈÄ¿Í È¸º¹ ½Ã°£À» °³¼±ÇÏ´Â µ¥ ÇʼöÀûÀÎ °ÍÀ¸·Î ÀÔÁõµÇ¾ú½À´Ï´Ù. °£Áú, ³úÁ¾¾ç, ÆÄŲ½¼º´°ú °°Àº ½Å°æ Áúȯ¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ¸ç, ÃÖÁ¾ »ç¿ëó´Â ÁÖ·Î º´¿ø, Àü¹® Ŭ¸®´Ð ¹× ¿¬±¸ ±â°üÀÔ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¤È®µµ¿Í ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â MRI ±â¼úÀÇ ¹ßÀü µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ°í °í·ÉÈ­ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀå ±âȸµµ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿µ»ó ÆÇµ¶À» °­È­Çϰí ÀΰøÁö´ÉÀ» ÅëÇÕÇØ °³ÀÎÈ­µÈ Ä¡·á °èȹÀ» ¼ö¸³ÇÏ´Â °ÍÀº Çõ½ÅÀÇ ÀáÀç·ÂÀ» º¸¿©ÁÖ´Â ºÐ¾ßÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 38¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 40¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 54¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 4.84%

±×·¯³ª ³ôÀº Àåºñ ºñ¿ë°ú º¹ÀâÇÑ ±â¼úÀ» ´Ù·ê ¼ö ÀÖ´Â ¼÷·ÃµÈ Àü¹®°¡¿¡ ´ëÇÑ ¼ö¿ä µî ¸î °¡Áö ÇѰè¿Í °úÁ¦°¡ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ ¹× »óȯ °ü·Ã ¹®Á¦´Â ƯÈ÷ ÀÇ·á ½Ã½ºÅÛÀÌ Àß °®Ãß¾îÁöÁö ¾ÊÀº ½ÅÈï ½ÃÀå¿¡¼­ ºü¸¥ ½ÃÀå ħÅõ¸¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀÌ Ä¡¿­Çϰí, ÁÖ¿ä ±â¾÷µéÀÌ ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí Àֱ⠶§¹®¿¡ °æÀï·ÂÀ» À¯ÁöÇϱâ À§Çؼ­´Â Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù. »õ·Î¿î ½ÃÀå ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇÑ ¹æ¾ÈÀ¸·Î´Â AI ±â¹Ý Ç÷§Æû °³¹ß¿¡ ´ëÇÑ ÅõÀÚ, ±â¼ú Á¢±Ù¼ºÀ» È®´ëÇϱâ À§ÇÑ ÆÄÆ®³Ê½Ê, »õ·Î¿î Ä¡·á ¿ëµµ¸¦ °ËÁõÇϱâ À§ÇÑ ÀÓ»ó½ÃÇè ÇÁ·Î±×·¥ È®´ë, ÀÇ·á°è¿Í ȯÀÚ ¸ðµÎ¿¡°Ô MRI À¯µµÇÏ ±â¼úÀÇ ÀÌÁ¡¿¡ ´ëÇØ ±³À°ÇÏ´Â µ¥ ÁßÁ¡À» µÎ´Â °Í µîÀÌ ÀÖ½À´Ï´Ù. ±³À°¿¡ ÁßÁ¡À» µÎ¸é äÅ÷üÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ ÇÙ½ÉÀº MRI À¯µµÇÏ ¼ÒÀÛ¼úÀÇ ½Ã¼ú È¿À²¼º, ºñ¿ë È¿À²¼º ¹× Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â °ÍÀÔ´Ï´Ù. Áö¼ÓÀûÀÎ ¼ºÀåÀ» À§Çؼ­´Â ±ÔÁ¦ À庮À» ±Øº¹ÇÏ°í »óȯ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ Áøº¸ÀûÀÎ Á¢±Ù ¹æ½Äµµ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿ªÇп¡ ºñÃß¾î º¼ ¶§, ½ÃÀåÀº ±â¼ú ¹ßÀü°ú ´õ ¸¹Àº Áö¿ª¿¡¼­ÀÇ Ã¤Åà Ȯ´ë¿¡ ÈûÀÔ¾î ºü¸£°Ô ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°èÀûÀ¸·Î ºü¸£°Ô Áõ°¡ÇÏ´Â ³ëÀÎ Àα¸¿¡ µû¸¥ ³úÁ¾¾ç À¯º´·ü Áõ°¡
    • Àúħ½ÀÀû ³ú¼ö¼úÀÇ Ã¤Åà ±ÞÁõ
    • ³ú Áúȯ Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ È¯ÀÚ ÀÎ½Ä Á¦°í
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • MRI À¯µµÇÏ ½Å°æ¿Ü°úÀû ÀýÁ¦¼ú°ú °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ½ÅÈï±¹ÀÇ ÀÇ·áºñ ÁöÃâÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.
    • ½Å°æ¿Ü°úÀû ÀýÁ¦¼ú¿¡ ´ëÇÑ ±â¼ú ¹ßÀü°ú ¿¬±¸ Ȱµ¿ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ¼÷·ÃµÈ ÀÎÀç ºÎÁ·

Portre's Five Forces: MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀåÀ» Ž»öÇϱâ À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º MRI À¯µµÇÏ ½Å°æ¿Ü°úÀû ÀýÁ¦¼ú ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

MRI À¯µµÇÏ ½Å°æ¿Ü°úÀû ÀýÁ¦¼ú ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå : Á¦Ç°º°

  • ¾×¼¼¼­¸®
  • MRI À¯µµ Áý¼Ó ÃÊÀ½ÆÄ ½Ã½ºÅÛ
  • MRI À¯µµ ·¹ÀÌÀú ÀýÁ¦ ½Ã½ºÅÛ
  • MRI À¯µµ RF ÀýÁ¦ ½Ã½ºÅÛ

Á¦7Àå MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Monteris Medical Corporation
  • Seattle Children's Hospital
  • Siemens AG
  • SternMed GmbH
LSH

The MRI Guided Neurosurgical Ablation Market was valued at USD 3.89 billion in 2023, expected to reach USD 4.07 billion in 2024, and is projected to grow at a CAGR of 4.84%, to USD 5.42 billion by 2030.

The scope of MRI Guided Neurosurgical Ablation encompasses the use of MRI technology to guide minimally invasive surgical procedures intended to ablate or remove predefined volumes of brain tissue. This technology proves essential as it allows for precise targeting of pathologies, reducing potential damage to surrounding healthy tissue, thereby enhancing patient outcomes and recovery times. Its applications are broad, spanning neurological disorders such as epilepsy, brain tumors, and Parkinson's disease, while the end-use segments mainly involve hospitals, specialty clinics, and research institutions. Key growth factors include increasing prevalence of neurological disorders, rising demand for minimally invasive surgeries, and advancements in MRI technology that improve accuracy and safety. As healthcare infrastructure develops and aging populations expand, opportunities for market growth similarly enlarge. Integrating artificial intelligence for enhanced imaging interpretation and personalized treatment planning represents a potential area for innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 3.89 billion
Estimated Year [2024] USD 4.07 billion
Forecast Year [2030] USD 5.42 billion
CAGR (%) 4.84%

However, several limitations and challenges could inhibit market growth, such as high equipment costs and a demand for skilled professionals capable of operating complex technologies. Furthermore, regulatory and reimbursement challenges might impede swift market penetration, especially in developing regions with less robust healthcare systems. The highly competitive market landscape, with prominent players heavily investing in R&D, necessitates continuous innovation to maintain a competitive edge. Recommendations to seize emerging market opportunities include investments in AI-driven platform development, partnerships for broadening technology access, and expanding clinical trial programs to validate new therapeutic applications. Enhanced focus on educating both the medical community and patients about the benefits of MRI-guided procedures could drive adoption rates. Innovations should center on improving the procedural efficiency, cost-effectiveness, and therapeutic outcomes of MRI-guided ablations. A progressive approach to overcoming regulatory obstacles and addressing reimbursement issues is also crucial for sustainable growth. Given these dynamics, the market is expected to continue evolving rapidly, characterized by technological advancements and increasing adoption across more geographical regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving MRI Guided Neurosurgical Ablation Market

The MRI Guided Neurosurgical Ablation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
    • Surge in the adoption of minimally invasive neurosurgeries
    • Rise in the awareness of brain disorder diagnosis and treatment among patients
  • Market Restraints
    • High cost associated with the MRI guided neurosurgical ablation
  • Market Opportunities
    • Rapidly growing healthcare expenditures in emerging nations
    • Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
  • Market Challenges
    • Lack of skilled manpower

Porter's Five Forces: A Strategic Tool for Navigating the MRI Guided Neurosurgical Ablation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the MRI Guided Neurosurgical Ablation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the MRI Guided Neurosurgical Ablation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the MRI Guided Neurosurgical Ablation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the MRI Guided Neurosurgical Ablation Market

A detailed market share analysis in the MRI Guided Neurosurgical Ablation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the MRI Guided Neurosurgical Ablation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the MRI Guided Neurosurgical Ablation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the MRI Guided Neurosurgical Ablation Market

A strategic analysis of the MRI Guided Neurosurgical Ablation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the MRI Guided Neurosurgical Ablation Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Cook Group Incorporated, Monteris Medical Corporation, Seattle Children's Hospital, Siemens AG, and SternMed GmbH.

Market Segmentation & Coverage

This research report categorizes the MRI Guided Neurosurgical Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, MRI Guided Focused Ultrasound Systems, MRI Guided Laser Ablation Systems, and MRI Guided RF Ablation Systems.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
      • 5.1.1.2. Surge in the adoption of minimally invasive neurosurgeries
      • 5.1.1.3. Rise in the awareness of brain disorder diagnosis and treatment among patients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the MRI guided neurosurgical ablation
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapidly growing healthcare expenditures in emerging nations
      • 5.1.3.2. Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled manpower
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. MRI Guided Neurosurgical Ablation Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. MRI Guided Focused Ultrasound Systems
  • 6.4. MRI Guided Laser Ablation Systems
  • 6.5. MRI Guided RF Ablation Systems

7. MRI Guided Neurosurgical Ablation Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas MRI Guided Neurosurgical Ablation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific MRI Guided Neurosurgical Ablation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa MRI Guided Neurosurgical Ablation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Cook Group Incorporated
  • 3. Monteris Medical Corporation
  • 4. Seattle Children's Hospital
  • 5. Siemens AG
  • 6. SternMed GmbH
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦